Cortical inhibitory neurons and schizophrenia

Lewis, David A., Hashimoto, Takanori, Volk, David W.·2005·Nature Reviews Neuroscience

Cited by (1,012)

Items 401–500 of 1,012

  1. Decoupling of Sleep-Dependent Cortical and Hippocampal Interactions in a Neurodevelopmental Model of Schizophrenia
    Keith Geoffrey Phillips, Ullrich Bartsch, Andrew P. McCarthy, Dale M. Edgar, Mark David Tricklebank, Keith A. Wafford, Matthew W. Jones · 2012 · Neuron
  2. Nonsteroidal Anti-Inflammatory Treatment Prevents Delayed Effects of Early Life Stress in Rats
    Heather C. Brenhouse, Susan L. Andersen · 2011 · Biological Psychiatry
  3. Interneuron Diversity in Layers 2–3 of Monkey Prefrontal Cortex
    Aleksey V. Zaitsev, Nadezhda V. Povysheva, Guillermo González‐Burgos, Diana C. Rotaru, Kenneth N. Fish, Leonid S. Krimer, David A. Lewis · 2008 · Cerebral Cortex
  4. Dorsolateral Prefrontal Cortex GABA Concentration in Humans Predicts Working Memory Load Processing Capacity
    Jong H. Yoon, Anthony Grandelis, Richard J. Maddock · 2016 · Journal of Neuroscience
  5. Generation of Cre-transgenic mice using Dlx1/Dlx2 enhancers and their characterization in GABAergic interneurons
    Gregory B. Potter, Magdalena A. Petryniak, Eugenia Shevchenko, Gabriel L. McKinsey, Marc Ekker, John L.R. Rubenstein · 2008 · Molecular and Cellular Neuroscience
  6. Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia
    Tsung-Ung Wilson Woo, Amy M. Kim, Emma Viscidi · 2008 · Brain Research
  7. A quantitative theory of the functions of the hippocampal CA3 network in memory
    Edmund T. Rolls · 2013 · Frontiers in Cellular Neuroscience
  8. 5-HT2C receptors in psychiatric disorders: A review
    Abdeslam Chagraoui, Florence Thibaut, Mohamed Skiba, Christian Thuillez, Michel Bourin · 2015 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  9. Human Laboratory Studies on Cannabinoids and Psychosis
    Mohamed A. Sherif, Rajiv Radhakrishnan, Deepak Cyril D’Souza, Mohini Ranganathan · 2016 · Biological Psychiatry
  10. Dopamine Increases Inhibition in the Monkey Dorsolateral Prefrontal Cortex through Cell Type-Specific Modulation of Interneurons
    Sven Kröner, Leonid S. Krimer, David A. Lewis, Germán Barrionuevo · 2006 · Cerebral Cortex
  11. Histone modifications, DNA methylation, and Schizophrenia
    Gavin, David P., Sharma, Rajiv P. · 2010 · Neuroscience & Biobehavioral Reviews
  12. Reversal learning and attentional set-shifting in mice
    Gregory B. Bissonette, Elizabeth M. Powell · 2011 · Neuropharmacology
  13. Upregulation of TET1 and downregulation of APOBEC3A and APOBEC3C in the parietal cortex of psychotic patients
    Erbo Dong, David P. Gavin, Yongjun Chen, John M. Davis · 2012 · Translational Psychiatry
  14. Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism
    I Braun, Just Genius, Heinz Grunze, Andreas Bender, Hans‐Jürgen Möller, Dan Rujescu · 2007 · Schizophrenia Research
  15. Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice
    Joerg Neddens, Andrés Buonanno · 2009 · Hippocampus
  16. Astrocyte‐derived kynurenic acid modulates basal and evoked cortical acetylcholine release
    Amy Zmarowski, Hui‐Qiu Wu, Julie M. Brooks, Michelle C Potter, Roberto Pellicciari, Robert M. Schwarcz, John P. Bruno · 2009 · European Journal of Neuroscience
  17. Effects of γ-Aminobutyric Acid–Modulating Drugs on Working Memory and Brain Function in Patients With Schizophrenia
    Menzies, Lara, Ooi, Cinly, Kamath, Shri, Suckling, John, McKenna, Peter, Fletcher, Paul, Bullmore, Ed, Stephenson, Caroline · 2007 · Archives of General Psychiatry
  18. Genetic Models of Sensorimotor Gating: Relevance to Neuropsychiatric Disorders
    Susan B. Powell, Martin Weber, Mark A. Geyer · 2011 · Current topics in behavioral neurosciences
  19. Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia
    Kara A. Kittelberger, Elizabeth E. Hur, Saba Sazegar, Vidya Keshavan, Bernát Kocsis · 2011 · Brain Structure and Function
  20. Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?
    Michael J. Gandal, R. L. Anderson, Eddie N. Billingslea, Greg C. Carlson, Timothy P. L. Roberts, Steven J. Siegel · 2012 · Genes Brain & Behavior
  21. Lamina-Specific Alterations in Cortical GABAA Receptor Subunit Expression in Schizophrenia
    Mónica Beneyto, Andrew Abbott, Takanori Hashimoto, David A. Lewis · 2010 · Cerebral Cortex
  22. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Tocilizumab, An Interleukin-6 Receptor Antibody, For Residual Symptoms in Schizophrenia
    Ragy R. Girgis, Adam Ciarleglio, Tse Hwei Choo, Gregory Haynes, Joan M. Bathon, Serge Cremers, Joshua T. Kantrowitz, Jeffrey Alan Lieberman, Alan S. Brown · 2017 · Neuropsychopharmacology
  23. Examining and Modulating Neural Circuits in Psychiatric Disorders With Transcranial Magnetic Stimulation and Electroencephalography: Present Practices and Future Developments
    Fabio Ferrarelli, Mary Louise Phillips · 2021 · American Journal of Psychiatry
  24. Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats
    Abekawa, Tomohiro, Ito, Koki, Nakagawa, Shin, Koyama, Tsukasa · 2007 · Psychopharmacology
  25. Decoding the Transcriptional Response to Ischemic Stroke in Young and Aged Mouse Brain
    Androvic, Peter, Kirdajova, Denisa, Tureckova, Jana, Zucha, Daniel, Rohlova, Eva, Abaffy, Pavel, Kriska, Jan, Valny, Martin, Anderova, Miroslava, Kubista, Mikael et al. · 2020 · Cell Reports
  26. Magnetoencephalography in Twins Reveals a Strong Genetic Determination of the Peak Frequency of Visually Induced Gamma-Band Synchronization
    Stan van Pelt, Dorret Irene Boomsma, Pascal Fries · 2012 · Journal of Neuroscience
  27. Contributions of the d-serine pathway to schizophrenia
    Viviane Labrie, Albert H.C. Wong, John Roder · 2011 · Neuropharmacology
  28. In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric Disorders
    Harry Pantazopoulos, Sabina Berretta · 2015 · Neural Plasticity
  29. Prenatal exposure to environmental insults and enhanced risk of developing Schizophrenia and Autism Spectrum Disorder: focus on biological pathways and epigenetic mechanisms
    Nadia Cattane, Juliet Richetto, Annamaria Cattaneo · 2018 · Neuroscience & Biobehavioral Reviews
  30. Gamma oscillations in schizophrenia: Mechanisms and clinical significance
    Yinming Sun, Faranak Farzan, Mera S. Barr, Kenji Kirihara, Paul Bernard Fitzgerald, Gregory A. Light, Zafiris Jeff Daskalakis · 2011 · Brain Research
  31. Working Memory Encoding and Maintenance Deficits in Schizophrenia: Neural Evidence for Activation and Deactivation Abnormalities
    Alan Anticevic, Grega Repovš, Deanna M. Barch · 2011 · Schizophrenia Bulletin
  32. Neuregulin-1/ErbB4 Signaling Regulates Visual Cortical Plasticity
    Sun, Yanjun, Ikrar, Taruna, Davis, Melissa F., Gong, Nian, Zheng, Xiaoting, Luo, Z. David, Lai, Cary, Mei, Lin, Holmes, Todd C., Gandhi, Sunil P. et al. · 2016 · Neuron
  33. Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia
    Daniel J. Lodge, Anthony A. Grace · 2008 · Neurotoxicity Research
  34. Cortical source estimates of gamma band amplitude and phase are different in schizophrenia
    Peter D. Teale, Dan Collins, Keeran Maharajh, Donald C. Rojas, Eugene Kronberg, Martin L Reite · 2008 · NeuroImage
  35. Hippocampal Interneurons in Bipolar Disorder
    Konradi, Christine, Zimmerman, Eric I., Yang, C. Kevin, Lohmann, Kathryn M., Gresch, Paul, Pantazopoulos, Harry, Berretta, Sabina, Heckers, Stephan · 2010 · Archives of General Psychiatry
  36. Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia
    Alireza Mohammadi, Ehsan Rashidi, Vahid Ghasem Amooeian · 2018 · Psychiatry Research
  37. ERP Repetition Effects and Mismatch Negativity Generation
    Torsten Baldeweg · 2007 · Journal of Psychophysiology
  38. A Thalamo-Hippocampal-Ventral Tegmental Area Loop May Produce the Positive Feedback that Underlies the Psychotic Break in Schizophrenia
    John E. Lisman, Hyun Jae Pi, Yuchun Zhang, Nonna A. Otmakhova · 2010 · Biological Psychiatry
  39. Parvalbumin-Positive Basket Interneurons in Monkey and Rat Prefrontal Cortex
    Nadya V. Povysheva, Aleksey V. Zaitsev, Diana C. Rotaru, Guillermo González‐Burgos, David A. Lewis, Leonid S. Krimer · 2008 · Journal of Neurophysiology
  40. Glutamatergic correlates of gamma-band oscillatory activity during cognition: A concurrent ER-MRS and EEG study
    Níall Lally, Paul Gerald Mullins, Mark V. Roberts, Darren Price, Thomas Gruber, Corinna Haenschel · 2013 · NeuroImage
  41. Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment
    Leyre Urigüen, María Julia García-Fuster, Luis Felipe Callado, Benito Morentín, Romano La Harpe, Vicent Casadó, Carmen Lluís, Rafael Franco, Jesús A. Garcı́a-Sevilla, J. Javier Meana · 2009 · Psychopharmacology
  42. Visual Masking in Schizophrenia: Overview and Theoretical Implications
    M. F. Green, Junghee Lee, Jonathan K. Wynn, Kristopher I. Mathis · 2011 · Schizophrenia Bulletin
  43. Impact of adolescent sucrose access on cognitive control, recognition memory, and parvalbumin immunoreactivity
    Amy Claire Reichelt, Simon Killcross, Luke D. Hambly, Margaret J. Morris, Reginald Frederick Westbrook · 2015 · Learning & Memory
  44. Insights into Cortical Oscillations Arising from Optogenetic Studies
    Vikaas Singh Sohal · 2012 · Biological Psychiatry
  45. Interstitial ions: A key regulator of state-dependent neural activity?
    Rune Nguyen Rasmussen, John O’Donnell, Fengfei Ding, Maiken Nedergaard · 2020 · Progress in Neurobiology
  46. Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration
    Gómez de San José, Nerea, Massa, Federico, Halbgebauer, Steffen, Oeckl, Patrick, Steinacker, Petra, Otto, Markus · 2022 · Journal of Neural Transmission
  47. Traumatic Brain Injury and Neuronal Functionality Changes in Sensory Cortex
    Simone F. Carron, Dasuni Sathsara Alwis, Ramesh Rajan · 2016 · Frontiers in Systems Neuroscience
  48. Neural Synchrony in Schizophrenia: From Networks to New Treatments
    Judith M. Ford, John Harrison Krystal, Daniel H. Mathalon · 2007 · Schizophrenia Bulletin
  49. The role of cortical inhibition in the pathophysiology and treatment of schizophrenia
    Daskalakis, Zafiris J., Fitzgerald, Paul B., Christensen, Bruce K. · 2007 · Brain Research Reviews
  50. Alterations in Metabotropic Glutamate Receptor 1α and Regulator of G Protein Signaling 4 in the Prefrontal Cortex in Schizophrenia
    David W. Volk, Stephen M. Eggan, David A. Lewis · 2010 · American Journal of Psychiatry
  51. The rise of a new GABA pharmacology
    Hanns Möhler · 2010 · Neuropharmacology
  52. Dysregulated protocadherin-pathway activity as an intrinsic defect in induced pluripotent stem cell–derived cortical interneurons from subjects with schizophrenia
    Zhicheng Shao, Haneul Noh, Woong Bin Kim, Peiyan Ni, Christine L. Nguyen, Sarah E. Cote, Elizabeth A. Noyes, Joyce Zhao, Teagan J. Parsons, James M. Park et al. · 2019 · Nature Neuroscience
  53. Coding and Binding of Color and Form in Visual Cortex
    Kiley J. Seymour, Colin W. G. Clifford, Nikos K. Logothetis, Andreas Bartels · 2009 · Cerebral Cortex
  54. Pharmacological activation of group-ii metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice
    Matrisciano, Francesco, Tueting, Patricia, Maccari, Stefania, Nicoletti, Ferdinando, Guidotti, Alessandro · 2012 · Neuropsychopharmacology
  55. A detailed analysis of localized J‐difference GABA editing: theoretical and experimental study at 4 T
    Lana G. Kaiser, Karl Young, Dieter Johannes Meyerhoff, Susanne G. Mueller, Gerald B. Matson · 2007 · NMR in Biomedicine
  56. Disrupted sensorimotor and social–cognitive networks underlie symptoms in childhood-onset schizophrenia
    Rebecca A. Berman, Stephen J. Gotts, Harrison M. McAdams, Dede K. Greenstein, François M. Lalonde, LIV S. CLASEN, Rebecca E. Watsky, Lorie Shora, Anna E. Ordóñez, Armin Raznahan et al. · 2015 · Brain
  57. Developmental pathology, dopamine, stress and schizophrenia
    Lodge, Daniel J., Grace, Anthony A. · 2011 · International Journal of Developmental Neuroscience
  58. GAD67 Deficiency in Parvalbumin Interneurons Produces Deficits in Inhibitory Transmission and Network Disinhibition in Mouse Prefrontal Cortex
    Lazarus, M. S., Krishnan, K., Huang, Z. J. · 2015 · Cerebral Cortex
  59. In Vivo Measurement of GABA Transmission in Healthy Subjects and Schizophrenia Patients
    William Gordon Frankle, Raymond Y. Cho, Konasale M. R. Prasad, Neale Scott Mason, Jennifer Paris, Michael L. Himes, Christopher P. R. Walker, David A. Lewis, Rajesh Narendran · 2015 · American Journal of Psychiatry
  60. Microstructural and Functional Connectivity in the Developing Preterm Brain
    Julia Lubsen, Betty R. Vohr, Eliza H. Myers, Michelle Hampson, Cheryl Lacadie, Karen C. Schneider, Karol H. Katz, Robert Todd Constable, Laura R. Ment · 2011 · Seminars in Perinatology
  61. Reduced sleep spindle activity point to a TRN-MD thalamus-PFC circuit dysfunction in schizophrenia
    Fabio Ferrarelli, Giulio Tononi · 2016 · Schizophrenia Research
  62. Npas4: A Neuronal Transcription Factor with a Key Role in Social and Cognitive Functions Relevant to Developmental Disorders
    Laurence D. Coutellier, Simret Beraki, Pooneh Memar Ardestani, Nay Lui Saw, Mehrdad Shamloo · 2012 · PLoS ONE
  63. Theranostic Biomarkers for Schizophrenia
    Matea Nikolac Perković, Gordana Nedić Erjavec, Dubravka Švob Štrac, S. Uzun, O. Kozumplik, N. Pivac · 2017 · International Journal of Molecular Sciences
  64. The axon initial segment in nervous system disease and injury
    Shelly Alexandra Buffington, Matthew Neil Rasband · 2011 · European Journal of Neuroscience
  65. Specific Functions of Synaptically Localized Potassium Channels in Synaptic Transmission at the Neocortical GABAergic Fast-Spiking Cell Synapse
    Ethan M. Goldberg, Shigeo Watanabe, Su Ying Chang, Rolf H. Joho, Z. Josh Huang, Christopher S. Leonard, Bernardo Rudy · 2005 · Journal of Neuroscience
  66. NCAM in Neuropsychiatric and Neurodegenerative Disorders
    Leann H. Brennaman, Patricia F. Maness · 2009 · Advances in experimental medicine and biology
  67. Adolescent Maturation of Cortical Dopamine
    O’Donnell, Patricio · 2010 · Neurotoxicity Research
  68. Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801
    Alexei M. Bygrave, Simonas Masiulis, Elizabeth Nicholson, M Berkemann, Chris Barkus, Rolf Sprengel, Paul J. Harrison, Dimitri Michael Kullmann, David M. Bannerman, Dennis Kätzel · 2016 · Translational Psychiatry
  69. Prefrontal Cortical Circuits in Schizophrenia
    David W. Volk, David A. Lewis · 2010 · Current topics in behavioral neurosciences
  70. Epigenomic Dysregulation in Schizophrenia: In Search of Disease Etiology and Biomarkers
    Behnaz Khavari, Murray J. Cairns · 2020 · Cells
  71. The role of the phosphatidylinositide 3-kinase–protein kinase B pathway in schizophrenia
    Hans O. Kalkman · 2006 · Pharmacology & Therapeutics
  72. Altered Expression of Genes Involved in GABAergic Transmission and Neuromodulation of Granule Cell Activity in the Cerebellum of Schizophrenia Patients
    William Michael Bullock, Karen E. Cardon, Juan Bustillo, Rosalinda C. Roberts, Nora I. Perrone‐Bizzozero · 2008 · American Journal of Psychiatry
  73. Cortical Oscillations in Health and Disease
    Roger D. Traub, Miles A. Whittington · 2010
  74. Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models
    Louisa Lyon, Lisa M. Saksida, Timothy J. Bussey · 2011 · Psychopharmacology
  75. Transcript-Specific Associations of SLC12A5 (KCC2) in Human Prefrontal Cortex with Development, Schizophrenia, and Affective Disorders
    Ran Tao, Chao Li, Erin N. Newburn, Tianzhang Ye, Barbara K. Lipska, Mary M. Herman, Daniel R. Weinberger, Joel E. Kleinman, Thomas M. Hyde · 2012 · Journal of Neuroscience
  76. Deciphering the Disease Process of Schizophrenia: The Contribution of Cortical Gaba Neurons
    David A. Lewis, Takanori Hashimoto · 2007 · International review of neurobiology
  77. GABAergic Circuit Dysfunctions in Neurodevelopmental Disorders
    Bidisha Chattopadhyaya, Graziella Di Cristo · 2012 · Frontiers in Psychiatry
  78. Differentiating Patterns of Amygdala-Frontal Functional Connectivity in Schizophrenia and Bipolar Disorder
    Huan Liu, Yanqing Tang, Fay Y. Womer, G. Fan, T. Lu, Naomi R Driesen, L. Ren, Y. Wang, Yong He A, Hilary P. Blumberg et al. · 2013 · Schizophrenia Bulletin
  79. Autonomous vascular networks synchronize GABA neuron migration in the embryonic forebrain
    Chungkil Won, Zhicheng Lin, Peeyush Kumar Thankamani Pandit, Suyan Li, Lai Ding, Abdallah Elkhal, Gábor Szabó, Anju Vasudevan · 2013 · Nature Communications
  80. GABA System in Schizophrenia and Mood Disorders: A Mini Review on Third-Generation Imaging Studies
    Chiara Chiapponi, Federica Piras, Fabrizio Piras, Carlo Caltagirone, Gianfranco Spalletta · 2016 · Frontiers in Psychiatry
  81. Mechanism of BDNF Modulation in GABAergic Synaptic Transmission in Healthy and Disease Brains
    Christophe Porcher, Igor Medina, Jean‐Luc Gaïarsa · 2018 · Frontiers in Cellular Neuroscience
  82. Divergent Plasticity of Prefrontal Cortex Networks
    Bita Moghaddam, Houman Homayoun · 2007 · Neuropsychopharmacology
  83. Suppression of γ-Oscillations in the Dorsolateral Prefrontal Cortex following Long Interval Cortical Inhibition: A TMS–EEG Study
    Faranak Farzan, Mera S. Barr, Willy Wong, Robert E. Chen, Paul Bernard Fitzgerald, Zafiris Jeff Daskalakis · 2008 · Neuropsychopharmacology
  84. Electrogenic Tuning of the Axon Initial Segment
    Brian Clark, Ethan M. Goldberg, Bernardo Rudy · 2009 · The Neuroscientist
  85. Improved Reversal Learning and Working Memory and Enhanced Reactivity to Novelty in Mice with Enhanced GABAergic Innervation in the Dentate Gyrus
    Morellini, Fabio, Sivukhina, Elena, Stoenica, Luminita, Oulianova, Elena, Bukalo, Olena, Jakovcevski, Igor, Dityatev, Alexander, Irintchev, Andrey, Schachner, Melitta · 2010 · Cerebral Cortex
  86. Cellular Basis of Reduced Cortical Reelin Expression in Schizophrenia
    Sharon L. Eastwood, Paul J. Harrison · 2006 · American Journal of Psychiatry
  87. Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia
    Carlson, Gregory C., Talbot, Konrad, Halene, Tobias B., Gandal, Michael J., Kazi, Hala A., Schlosser, Laura, Phung, Quan H., Gur, Raquel E., Arnold, Steven E., Siegel, Steven J. · 2011 · Proceedings of the National Academy of Sciences
  88. Inhibition of parvalbumin-expressing interneurons results in complex behavioral changes
    James A. Brown, Teniel S Ramikie, M J Schmidt, Rita Báldi, Krassimira A. Garbett, Monika Everheart, L E Warren, Levente Gellért, Szatmár Horváth, Sachin Patel et al. · 2015 · Molecular Psychiatry
  89. Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder
    Stephen M. Eggan, Samuel R. Stoyak, Christopher D. Verrico, David A. Lewis · 2010 · Neuropsychopharmacology
  90. Schizophrenia susceptibility genes: emergence of positional candidates and future directions
    Joseph A. Gogos, David J. Gerber · 2006 · Trends in Pharmacological Sciences
  91. Kv3.1-containing K channels are reduced in untreated schizophrenia and normalized with antipsychotic drugs
    Yanagi, M, Joho, R H, Southcott, S A, Shukla, A A, Ghose, S, Tamminga, C A · 2014 · Molecular Psychiatry
  92. Otx2-PNN interaction to regulate cortical plasticity
    Bernard, Clémence, Prochiantz, Alain · 2016 · Neural Plasticity
  93. Medial frontal GABA is lower in older schizophrenia: a MEGA-PRESS with macromolecule suppression study
    Laura M. Rowland, Benjamin W. Krause, S. Andrea Wijtenburg, Robert P. McMahon, Joshua Chiappelli, Katie L. Nugent, Sarah J. Nisonger, Stephanie A. Korenic, Peter Kochunov, Liyi Elliot Hong · 2015 · Molecular Psychiatry
  94. Primate-specific origins and migration of cortical GABAergic neurons
    Zdravko Petanjek · 2009 · Frontiers in Neuroanatomy
  95. Endothelial cell-derived GABA signaling modulates neuronal migration and postnatal behavior
    Suyan Li, Peeyush Kumar Thankamani Pandit, Sampada Joshee, Timo Kirschstein, Sivan Subburaju, Jahan S. Khalili, Jonas Kloepper, Chuang Du, Abdallah Elkhal, Gábor Szabó et al. · 2017 · Cell Research
  96. Pyramidal Neurons in Rat Prefrontal Cortex Projecting to Ventral Tegmental Area and Dorsal Raphe Nucleus Express 5-HT2A Receptors
    Pablo Moriña Vázquez, Roser Cortés, Francesc Artigas · 2008 · Cerebral Cortex
  97. Transcranial magnetic stimulation: A neuroscientific probe of cortical function in schizophrenia
    McClintock, Shawn M., Freitas, Catarina, Oberman, Lindsay, Lisanby, Sarah H., Pascual-Leone, Alvaro · 2011 · Biological Psychiatry
  98. Cxcr4 regulation of interneuron migration is disrupted in 22q11.2 deletion syndrome
    Daniel W. Meechan, Eric S. Tucker, Thomas Michael Maynard, Anthony‐Samuel LaMantia · 2012 · Proceedings of the National Academy of Sciences
  99. S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis
    Alessandro Guidotti, W. Brad Ruzicka, Dennis R. Grayson, Marin Veldić, Graziano Pinna, John M. Davis, Erminio Costa · 2007 · Neuroreport
  100. Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia
    Phillips, K.G., Cotel, M.C., McCarthy, A.P., Edgar, D.M., Tricklebank, M., O’Neill, M.J., Jones, M.W., Wafford, K.A. · 2012 · Neuropharmacology